Relationship between serum levels of interleukin-6, tumor necrosis factor-α and bone turnover markers in prostate cancer patients

Endocrine Journal

Volumn 45, Issue 2, 1998, Pages 183-189

  Akimoto, Susumu ^a   Okumura, Akiou ^a   Fuse, Hideki ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Carboxy terminal propeptide of type I procollagen (PICP); Carboxy terminal telopeptide of type I collagen (ICTP); Interleukin 6; Prostate cancer; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 6; PROCOLLAGEN; PROSTATE SPECIFIC ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD LEVEL; BONE METASTASIS; BONE TURNOVER; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; OSSIFICATION; OSTEOLYSIS; PROSTATE CANCER;

EID: 0031834165     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.45.183     Document Type: Article

References (30)

1. Kishimoto T (1989) The biology of interleukin-6. Blood 74: 1-10.
2. Le J, Vilcek J (1989) Interleukin-6: A multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 61: 588-602.
3. Siegall CB, Schwab G, Nordan RP, FitzGerald DJ, Pastan I (1990) Expression of the interleukin 6 receptor and interleukin 6 in prostatic carcinoma cells. Cancer Res 50: 7786-7788.
4. Okamoto M, Lee C, Oyasu R (1997) Interleukin-6 as a paracrine and autocrine growth factors in human prostatic carcinoma cells in vitro. Cancer Res 57: 141-146.
5. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, Kishimoto Y, Suda T (1990) IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145: 3297-3303.
6. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams J, Boyce B, Broxmeyer H, Manolagas SC (1992) Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 257: 88-91.
7. Manolagas SC, Jilka RL (1995) Bone marrow, cytokines and bone remodelling. N Engl J Med 332: 305-311.
8. Gersa D (1987) International lconference on tumor necrosis factor and related cytotoxins. Immunobiology 175: 1-143.
9. Rifas L, Kenney JS, Pacifici R, Cheng S-L, Dawson LL, Avioli LV (1995) Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: Evidence that induction by interleukin-1 and tumor necrosis factor-α is not regulated by ovarian steroids. Endocrinology 136: 4056-4067.
10. Calvo MS, Eyre DR, Gundberg CM (1996) Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 17: 333-368.
11. Melkko J, Niemi S, Risteli L, Risteli J (1990) Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 36: 1328-1332.
12. Francini G, Gonnelli S, Petrioli R, Bruni S, Marsili S, Aquino A, Camporeale A (1993) Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases. Cancer Epidemiol Biomarkers and Prev 2: 125-129.
13. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L (1993) Radioimmunoassay for pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 39: 635-640.
14. Ezzat S, Melmed S, Endres D, Eyre DR, Singer FR (1993) Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab 76: 1452-1457.
15. Garnero P, Vassy V, Bertholin A, Riou JP, Delmas PD (1994) Markers of bone turnover in hyperthyroidism and the effects of treatment. J Clin Endocrinol Metab 78: 955-959.
16. Kushida K, Takahashi M, Kawana K, Inoue T (1996) Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients. J Clin Endocrinol Metab 80: 2447-2450.
17. Miyakawa M, Tsushima T, Demura H (1996) Carboxy-terminal propeptide of type I procollagen (PICP) and carboxy-terminal telopeptide of type I collagen (ICTP) as sensitive markers of bone metabolism in thyroid disease. Endocr J 43: 701-708.
18. Grey A, Mitnick M-A, Shapses S, Ellison A, Gundberg C, Insogna K (1996) Circulating levels of interleukin-6 and tumor necrosis factor-α are elevated in primary hyperparathyroidism and correlate with markers of bone resorption - A clinical research center study. J Clin Endocrinol Metab 81: 3450-3454.
19. Baigrie RJ, Lamont PM, Kwiatkowski D, Dallman MJ, Morris PJ (1992) Systemic cytokine response after major surgery. Br J Surg 79: 757-760.
20. Igarashi T, Takahashi H, Tanaka M, Murakami S (1996) Serum interleukin-6 levels after urologic operations. Int J Urol 3: 340-342.
21. Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd B, Soloway S, Moinuddin M (1988) Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 61: 195-202.
22. Lange PH, Ercole CJ, Lightner DJ, Fraley EE, Vessella R (1989) The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 141: 873-879.
23. Greenfield EM, Gornik SA, Horowitz MC, Donahue HJ, Shaw SM (1993) Regulation of cytokine expression in osteoblasts by parathyroid hormone: Rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA. J Bone Miner Res 8: 1163-1171.
24. Sakagami Y, Girasole G, Yu X-P, Boswell HS, Manolagas SC (1993) Stimulation of interleukin-6 production by either calcitonin gene-related peptide or parathyroid hormone in two phenotypically distinct bone marrow-derived murine stromal cell lines. J Bone Miner Res 8: 811-816.
25. Akimoto S, Akakura K, Shimazaki J (1996) Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer. Jpn J Clin Oncol 26: 157-163.
26. Roodman GD (1996) Advances in bone biology: The osteoclast. Endocr Rev 17: 308-332.
27. Twillie DA, Eisenberger MA, Carducci MA, Hseih W-S, Kim WY, Simons JW (1995) Interleukin-6: A candidate mediator of human prostate cancer morbidity. Urology 45: 542-549.
28. De La Mata J, Uy HL, Guise TA, Story B, Boyce BF, Mundy GF, Roodman GD (1995) IL-6 enhances hypercalcemia and bone resorption mediated by PTH-rP in vivo. J Clin Invest 95: 2846-2852.
29. Iwamura M, di Sant'Agnese PA, Wu G, Benning CM, Cockett ATK, Deftos LJ, Abrahamsson P-A (1993) Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer. Cancer Res 53: 1724-1726.
30. Mahadevia PS, Ramaswamy A, Greenwald ES, Wollner DI, Markham D (1983) Hypercalcemia in prostatic carcinoma. Report of eight cases. Arch Intern Med 143: 1339-1342.